ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Vistagen Therapeutics Inc

Vistagen Therapeutics Inc (VTGN)

2.72
0.065
( 2.45% )
Updated: 06:08:04

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 176k178k277k412k197k84k183k234k
Operating Income -12.24M-7M-6.78M-7.88M-11.36M-12.13M-14.23M-15.12M
Pre Tax Income -12.23M-6.9M-6.59M-6.35M-9.52M-10.73M-12.95M-14.09M
Net Income -12.23M-6.9M-6.59M-6.35M-9.52M-10.73M-12.96M-14.09M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -12.24M-7M-6.78M-7.88M-11.05M-12.13M-14.23M-15.12M
EBITDA -12.21M-6.97M-6.75M-7.85M-11.33M-12.1M-14.19M-15.08M
Year End 31 March 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.25M0001.09M1.11M-227k1.06M
Operating Income -10.25M-14.2M-24.56M-20.8M-17.93M-47.78M-59.27M-33.02M
Pre Tax Income -10.25M-14.34M-24.59M-20.77M-17.93M-47.76M-59.24M-29.36M
Net Income -11.62M-15.58M-25.73M-22.04M-42.32M-48.71M-59.25M-29.36M
Preferred Dividends -1.37M-1.23M-1.14M-1.26M-24.39M-946k00
Basic Earnings Per Share (EPS) -0.873-0.576-0.552-0.413-0.229-0.231-0.281-0.948
EBIT -10.25M-14.34M-24.58M-20.8M-17.93M-47.78M-59.27M-32.71M
EBITDA -10.19M-14.12M-24.47M-20.7M-17.82M-47.63M-59.14M-32.89M